ArthNow Logo
ArthNow
•2 min read•
✦Reported by Business Line

ICICI Bank hits 52-week high before retreating; Morgan Stanley adds to focus list

ICICI Bank hits 52-week high before retreating; Morgan Stanley adds to focus list
Source: Business Line

Executive Brief • Key Highlights

Fast factual intelligence distilled for busy investors, executives, and answer bots:

  • ✓ICICI Bank shares touched a 52-week high of ₹1,616 on Wednesday before trading at ₹1,577.70.
  • ✓The stock got a boost after Morgan Stanley added the bank to its focus lists.
  • ✓Investors now look forward to seven institutional events scheduled between November 16 and 19 to discuss the bank’s future growth plans.

Story at a Glance

Category
Indian Markets
Reported By
Business Line
Reading Speed
2 Minute(s)
Market Focus
India Economy

Stock trades at ₹1,577.70 amid bullish analyst calls from Morgan Stanley and Motilal Oswal; bank to attend multiple investor events next week

Shares of ICICI Bank touched a fresh 52-week high of ₹1,616 on the NSE on Wednesday before trimming gains, trading at ₹1,577.70, down 0.71 per cent from Monday's close of ₹1,589, as of 12.43 pm. The stock opened at its intraday peak and has since pulled back, with sell orders dominating at 68.34 per cent of total order flow against 31.66 per cent on the buy side. Traded volume stood at 184.92 lakh shares, with a traded value of ₹2,959.58 crore by early afternoon. The bank's market capitalisation stood at over ₹11.33 lakh crore.

🔒
Premium Content

Unlock the Full Story with ArthNow Premium

To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.

✓ Full Unabridged Reports✓ Executive Audio Briefs✓ 100% Ad-Free Reading
Verified Publication Source

Business Line

Read the full, original unfiltered story directly on the publisher's portal.

Visit Original Article

This brief is for information only and is not investment advice. ArthNow is not a SEBI-registered investment adviser and does not publish buy or sell recommendations. Original reporting is credited to the publisher named above. Read our editorial policy or report an error.